Chemokine receptor antagonists as HIV entry inhibitors

Expert Opinion on Therapeutic Patents

Volumn 14, Issue 2, 2004, Pages 251-255

[No Author Info available]

Author keywords

Antiviral agents; CC chemokine receptor (CCR)5; Chemokine receptor antagonists; CXC chemokine receptor (CXCR)4; Heterocycles; HIV; Piperidine

Indexed keywords

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); ANTIRETROVIRUS AGENT; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR5 INHIBITOR; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 INHIBITOR; ENFUVIRTIDE; N [4 [[[6,7 DIHYDRO 2 (4 METHYLPHENYL) 5H BENZOCYCLOHEPTEN 8 YL]CARBONYL]AMINO]BENZYL] N,N DIMETHYL 2H TETRAHYDROPYRAN 4 AMINIUM CHLORIDE; PROTEINASE INHIBITOR; RANTES; RNA DIRECTED DNA POLYMERASE INHIBITOR; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG TARGETING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IC 50; IN VITRO STUDY; IN VIVO STUDY; INJECTION SITE; NONHUMAN; PROTEIN TARGETING; SKIN IRRITATION; STRUCTURE ANALYSIS;

EID: 1242329947     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/eotp.14.2.251.26402     Document Type: Article

References (18)

1. DE CLERCQ E: Molecular targets for antiviral agents. J. Pharmacol. Exp. Ther. (2001) 297:1-10.
2. DE CLERCQ E: Antiviral drugs - current state of the art. J. Clin. Virol. (2001) 22:73-89.
3. VELLA S, PALMISANO L: Antiretroviral therapy: state of the HAART. Antiviral Res. (2000) 45:1-7.
4. JOLY V, YENY P: New trends in antiretroviral therapy of HIV infection. Eur. J. Int. Med. (2000) 11:301-308.
5. KAUFMANN GR, COOPER DA: Antiretroviral therapy of HIV-1 infection: established treatment strategies and new therapeutic options. Curr. Opin. Microbiol. (2000) 3:508-514.
6. BALZARINI J: Effect of antimetabolite drugs of nucleotide metabolism on the anti-human immunodeficiency virus activity of nucleoside reverse transcriptase inhibitors. Pharmacol. Ther. (2000) 87:175-187.
7. OGDEN RC, FLEXNER CW (Eds): Protease Inhibitors in AIDS Therapy. Marcel Dekker, New York, Basel (2001).
8. SCOZZAFAVA A, MASTROLORENZO A, SUPURAN CT: Agents that target cysteine residues of biomolecules and their therapeutic potential. Expert Opin. Ther. Patents (2001) 11:765-787.
9. MASTROLORENZO A, SCOZZAFAVA A, SUPURAN CT: Small molecule antagonists of chemokine receptors as emerging anti-HIV agents. Expert Opin. Ther. Patents (2001) 11:1245-1252.
10. SCOZZAFAVA A, OWA T, MASTROLORENZO A, SUPURAN CT: Anticancer and antiviral sulfonamides. Curr. Med. Chem. (2003) 10:925-953.
11. TOMARAS GD, GREENBERG ML: Mechanisms for HIV-1 entry: current strategies to interfere with this step. Curr. Infect. Dis. Rep. (2001) 3:93-99.
12. BLAIR WS, LIN PF, MEANWELL NA, WALLACE OB: HIV-1 entry - an expanding portal for drug discovery. Drug. Dev. Today (2000) 5:183-194.
13. KWONG PD, WYATT R, ROBINSON J, SWEETS RW, SODROSKI J, HENDRICKSON WA: Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature (1998) 393:648-659.
14. FERNANDEZ EJ, LOLIS E: Structure, function and inhibition of chemokines. Ann. Rev. Pharmacol. Toxicol. (2002) 42:469-499.
15. ROOT MJ, KAY MS, KIM PS: Design of an HIV-1 entry inhibitor. Science (2001) 291:884-888.
16. HENDRIX CW, FLEXNER C, MACFARLAND RT et al.: Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob. Agents Chemother. (2000) 44:1667-1673.
17. SHIRAISHI M, ARAMAKI Y, SETO M et al.: Discovery of novel, potent, and selective small-molecule CCR5 antagonists as anti-HIV-1 agents: synthesis and biological evaluation of anilide derivatives with a quaternary ammonium moiety. J. Med. Chem. (2000) 43:2049-2063.
18. SCOZZAFAVA A, MASTROLORENZO A, SUPURAN CT, Non-peptidic chemokine receptors antagonists as emerging anti-HIV agents. J. Enz. Inhib. Med. Chem. (2002) 17:69-76.